Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury

Anastasiia O. Sosnovtseva; Olga V. Stepanova; Olga V. Stepanova; Aleksei A. Stepanenko; Aleksei A. Stepanenko; Anastasia D. Voronova; Andrey V. Chadin; Marat P. Valikhov; Marat P. Valikhov; Marat P. Valikhov; Vladimir P. Chekhonin; Vladimir P. Chekhonin

doi:10.3389/fphar.2021.777628

Frontiers in Pharmacology (Jan 2022)

Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury

Anastasiia O. Sosnovtseva,
Olga V. Stepanova,
Olga V. Stepanova,
Aleksei A. Stepanenko,
Aleksei A. Stepanenko,
Anastasia D. Voronova,
Andrey V. Chadin,
Marat P. Valikhov,
Marat P. Valikhov,
Marat P. Valikhov,
Vladimir P. Chekhonin,
Vladimir P. Chekhonin

Affiliations

Anastasiia O. Sosnovtseva: Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia
Olga V. Stepanova: Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia
Olga V. Stepanova: Department of Neurohumoral and Immunological Research, National Medical Research Center of Cardiology, The Ministry of Health of the Russian Federation, Moscow, Russia
Aleksei A. Stepanenko: Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia
Aleksei A. Stepanenko: Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Moscow, Russia
Anastasia D. Voronova: Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia
Andrey V. Chadin: Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia
Marat P. Valikhov: Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia
Marat P. Valikhov: Department of Neurohumoral and Immunological Research, National Medical Research Center of Cardiology, The Ministry of Health of the Russian Federation, Moscow, Russia
Marat P. Valikhov: Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Moscow, Russia
Vladimir P. Chekhonin: Department of Fundamental and Applied Neurobiology, V.P. Serbsky National Medical Research Center of Psychiatry and Narcology, The Ministry of Health of the Russian Federation, Moscow, Russia
Vladimir P. Chekhonin: Department of Medical Nanobiotechnology, Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University, The Ministry of Health of the Russian Federation, Moscow, Russia

DOI: https://doi.org/10.3389/fphar.2021.777628
Journal volume & issue: Vol. 12

Abstract

Read online

The regeneration of nerve tissue after spinal cord injury is a complex and poorly understood process. Medication and surgery are not very effective treatments for patients with spinal cord injuries. Gene therapy is a popular approach for the treatment of such patients. The delivery of therapeutic genes is carried out in a variety of ways, such as direct injection of therapeutic vectors at the site of injury, retrograde delivery of vectors, and ex vivo therapy using various cells. Recombinant adenoviruses are often used as vectors for gene transfer. This review discusses the advantages, limitations and prospects of adenovectors in spinal cord injury therapy.

Published in Frontiers in Pharmacology

ISSN: 1663-9812 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://journal.frontiersin.org/journals/pharmacology

About the journal

Abstract

Keywords